Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Oxford Biomedica financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

£4.1

2024-10-29

Market Capitalization

£428.7 M

2024-10-29

Revenue

£168.7 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

GBPFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue66.8M64.1M87.7M142.8M140.0M89.5M128.8M168.7M
Cost of goods sold22.8M29.9M32.0M47.7M44.4M21.1M53.3M82.9M
Gross profit45.1M35.0M56.5M96.0M97.8M72.3M80.7M96.9M
Gross profit margin, %67.5%54.6%64.4%67.2%69.9%80.7%62.7%57.4%
Operating expense total34.1M42.1M52.4M62.7M123.0M128.4M97.7M99.5M
Depreciation and amortization4.4M5.8M9.6M12.5M26.4M28.7M22.4M19.8M
EBITDA11.0M(7.0M)4.1M33.3M(25.2M)(56.2M)(16.9M)(2.6M)
EBITDA margin, %16.4%-11.0%4.7%23.3%-18.0%-62.7%-13.2%-1.6%
EBIT6.6M(14.7M)(6.3M)20.7M(30.2M)(84.9M)(39.4M)(22.5M)
EBIT margin, %9.9%-23.0%-7.2%14.5%-21.6%-94.8%-30.6%-13.3%
Interest income71.0K104.0K34.0K973.0K4.9M3.2M2.4M
Interest expense6.2M5.6M912.0K888.0K8.8M11.2M10.5M14.5M
Pre tax profit5.0M(20.9M)(6.6M)19.9M(46.0M)(188.5M)(47.3M)(31.9M)
Income tax expense(2.5M)(4.8M)(327.0K)869.0K(817.0K)(4.4M)1.3M(1.3M)
Net Income7.5M(16.1M)(6.2M)19.0M(45.2M)(184.2M)(48.6M)(30.6M)

Footer menu